Module 10 Discussion: Disorders Of Erythrocyte Function

Module 10 Discussion Disorders Of Erythrocyte Function

Discuss: The module mentioned that sickle cell disease was an adaptive response against malaria. Why do you think such an adaptation occurred? Why do people who no longer live in parts of the world where malaria is prevalent still develop the disease? Your patient with chronic lung disease has just been diagnosed with secondary polycythemia. She asks you to explain this disease in language she can understand since she has no medical background. What would you say to her? You are a student doing summer healthcare work in a small village in Central America. You have been told that the local people have serious health problems related to iron deficiency anemia. There are no vitamins available for them to take. Consider alternative methods with which iron levels could be increased.

Paper For Above instruction

The interplay between genetic adaptations and environmental factors has often resulted in physiological traits that favor survival in specific regions. A striking example of this is sickle cell disease, which provides a fascinating case of how genetic mutation can offer a survival advantage against infectious diseases such as malaria. Understanding the historical, biological, and clinical aspects of these conditions provides insight into their persistence and prevalence, even among populations no longer exposed to their original environmental pressures.

Sickle cell disease is characterized by the production of abnormal hemoglobin, called hemoglobin S, which causes red blood cells to take on a sickle or crescent shape. These misshapen cells are less flexible and more prone to blockages in blood flow, leading to pain, organ damage, and other complications. The genetic mutation responsible for sickle cell trait is more common in regions where malaria is endemic—primarily sub-Saharan Africa, parts of the Middle East, and India—because carriers of the sickle cell trait (heterozygotes) are less susceptible to severe malaria. Malaria, caused by the Plasmodium parasite, infects red blood cells. In individuals with sickle cell trait, the parasite's lifecycle is disrupted within the sickle-shaped cells, conferring a survival advantage and thus increasing the likelihood of passing the trait to offspring. This evolutionary advantage led to the higher prevalence of sickle cell gene in these regions over generations.

Despite the decline of endemic malaria in some regions due to globalization, urbanization, and public health interventions, individuals with sickle cell traits or disease continue to be born. This persistence occurs because the gene remains part of the population's gene pool, and genetic traits do not disappear rapidly once established. Moreover, in some cases, migration and travel result in individuals being born in regions where malaria is still prevalent or carrying the gene from ancestors who lived in those regions. Consequently, sickle cell disease continues to affect people worldwide, regardless of current malaria exposure.

Regarding secondary polycythemia, this condition occurs when the body produces too many red blood cells in response to an external stimulus—in this case, chronic lung disease. These patients often have low oxygen levels because their lungs are unable to oxygenate the blood adequately. To compensate, the body signals the bone marrow to produce more red blood cells in an effort to increase oxygen delivery. This overproduction results in an increased blood volume, which can make the blood thicker and harder to flow, potentially leading to complications such as blood clots, hypertension, or stroke. In simple terms, secondary polycythemia is the body's way of trying to compensate for poor oxygen supply by making more red blood cells, which thickens the blood and can cause health problems if left unchecked.

As a healthcare worker explaining this to the patient, I would say: "Your body is making more red blood cells than usual because your lungs aren't able to bring enough oxygen into your blood. Think of it like your body trying to fix a problem—since it can't get enough oxygen from the lungs, it tries to make more red blood cells to carry the oxygen better. But when too many cells are produced, the blood becomes thicker, which can make your heart work harder and increase your risk of blood clots or stroke. We need to monitor and manage this to keep you safe and ensure your blood flows smoothly."

In small villages where iron deficiency anemia is common, and vitamins are unavailable, alternative strategies can be implemented to improve iron levels. Dietary interventions are the most accessible and sustainable options. Encouraging increased intake of iron-rich foods such as leafy green vegetables (spinach, kale), legumes (beans, lentils), lentils, and fortified grains can help. Additionally, promoting the consumption of vitamin C-rich foods (such as citrus fruits, tomatoes, and peppers) can enhance iron absorption from plant sources. Using traditional methods such as soaking, fermenting, or sprouting grains and legumes reduces phytates, naturally occurring compounds that inhibit iron absorption, thus increasing bioavailability.

Another alternative is the use of local iron-rich medicinal plants or herbal remedies, where culturally appropriate and evidence-based. For example, in some regions, certain herbs are believed to help improve blood health and can be included in the diet accordingly. Ensuring proper cooking techniques, such as cooking in cast iron pots, can also increase the iron content in food. Lastly, community health education about the importance of iron-rich diets and combining iron sources with vitamin C can have a significant impact on addressing anemia in resource-limited settings.

References

• African Journal of Medicine and Medical Sciences. (2020). Sickle cell disease: implications and management. AJMMS, 48(1), 1-13.
• World Health Organization. (2015). The global prevalence of anemia in 2011. WHO Document, WHO/MCH/13.01.
• Steinberg, M. H. (2008). Sickle cell disease. Expert Review of Hematology, 1(1), 23–34.
• Rees, D. C., Williams, T. N., & Napier, G. (2010). Sickle-cell disease. The Lancet, 376(9757), 2018-2031.
• Orrell, C. H., & McCarthy, R. (2018). Polycythemia vera and secondary causes. Australian Prescriber, 41(2), 52-55.
• World Health Organization. (2001). Iron deficiency anemia: assessment, prevention, and control: a guide for program managers. WHO/NHD/01.3.
• Kee, C., & Seo, S. (2021). Nutritional strategies for combating iron deficiency anemia. Journal of Nutrition & Food Sciences, 11(4), 754.
• Wahlqvist, M. L. (2013). Traditional diets, foods, and health: a view from the tropics. Asia Pacific Journal of Clinical Nutrition, 22(4), 725-744.
• Günther, P., & Löffler, P. (2016). Iron absorption and deficiency in resource-limited settings. Nutrition Reviews, 74(7), 453-462.
• Huffman, M. D., & Johnson, A. (2019). Herbal and dietary approaches to anemia management. Frontiers in Pharmacology, 10, 998.